Imaging Veteran to Lead WorldCare's Global Expansion
Boston, MA, November 19, 2014 -- WorldCare Clinical (WCC), a leading global provider of imaging services for clinical trials whose systems process over 250 million images annually, today announced that it has appointed Aaron Timm as Chief Executive Officer. Mr. Timm brings specialist knowledge of the expanding imaging environment and over 10 years of clinical research and executive management experience to WCC. He will be focused on delivering on a customer-centered strategy, driving business growth, operational scalability, and global expansion.
Prior to joining WCC, Mr. Timm served as CEO of Synarc, an imaging clinical research organization. He holds a B.S. in Foreign Service from Georgetown University and a law degree from Harvard Law School.
"The WorldCare Clinical Board and I are delighted to appoint a leader of Aaron's significant experience and capabilities at a time of growth. WCC has made significant progress in the creation and delivery of best-in-class imaging services as well as innovative independent pathology, clinical endpoint and clinical safety review services. Aaron's executive leadership and unique imaging experience will be essential as we continue to focus on delivering the highest quality of services and expanding our global offering," said Dr. Stephen Pomeranz, Chairman of the Board of WorldCare Clinical.
"With our scientific and radiological expertise, as well as our strengths in technology and project management, WorldCare offers sponsors a full-service imaging CRO committed to excellence in clinical research," stated Aaron Timm. "We have the financial resources and long-term commitment from our Board to continue to invest in innovation and the expansion of our capabilities. I am looking forward to the opportunities ahead working with Dr. Rick Walovitch, President, and the outstanding WorldCare team."
About WorldCare Clinical
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. Through proven strategic relationships, WCC is able to draw from the best subspecialty-trained, board-certified practicing physicians. From radiology and pathology to dermatology, oncology, cardiology and neurology, WCC experts are trained by WCC to a common and high-quality standard under a uniform system to maximize their precision and accuracy. With global headquarters in Boston, Massachusetts, the company has worked with thousands of sites in more than 50 countries. WCC's robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.
For more information on WCC's services, please visit our website at www.wcclinical.com.
Media Contact: Thomas O'Donnell, WorldCare Clinical, (513) 924-5183, email@example.com